![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10018 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-ORC1L/ORC1 |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human ORC1L/ORC1 |
產(chǎn)品訂購(gòu)信息:
英文名稱 Anti-ORC1L/ORC1
中文名稱 起始識(shí)別復(fù)合蛋白亞基1抗體規(guī)格
別 名 HSORC1; MmORC1; orc1; ORC1_HUMAN; ORC1L; Origin Recognition Complex 1; Origin recognition complex subunit 1 (yeast homolog) like; Origin recognition complex subunit 1; Origin recognition complex subunit 1 homolog; Origin recognition complex subunit 1 like (S. cerevisia; Origin recognition complex subunit 1 like; Origin recognition complex subunit 1 S. cerevisiae homolog like; Origin recognition complex, subunit 1 like (yeast); PARC1; Replication control protein 1.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 細(xì)胞周期蛋白 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 97kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human ORC1L/ORC1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
起始識(shí)別復(fù)合蛋白亞基1抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The initiation of DNA replication is a multi-step process that depends on the formation of pre-replication complexes, which trigger initiation (1). Among the proteins required for establishing these complexes are the origin recognition complex (ORC) proteins (1). ORC proteins bind specifically to origins of replication where they serve as scaffold for the assembly of additional initiation factors (1). Human ORC subunits 1-6 are expressed in the nucleus of proliferating cells and tissues, such as the testis (2). ORC1 and ORC2 are both expressed at equivalent concentrations throughout the cell cycle; however, only ORC2 remains stably bound to chromatin (3,4). ORC4 and ORC6 are also expressed constantly throughout the cell cycle (5,6). ORC2, ORC3, ORC4 and ORC5 form a core complex upon which ORC6 and ORC1 assemble (7,8). The formation of this core complex suggests that ORC proteins play a crucial role in the G1-S transition in mammalian cells (8).
Function : Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent, however specific DNA sequences that define origins of replication have not been identified so far. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication.
Subcellular Location : Nucleus.
Similarity : Belongs to the ORC1 family.
Contains 1 BAH domain.
Anti-Caspase-9/FITC 熒光素標(biāo)記白介素1-β轉(zhuǎn)化酶樣凋亡蛋白酶6抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-DcR3/FITC 熒光素標(biāo)記抗誘捕受體3抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Ceruloplasmin 銅藍(lán)蛋白抗體 規(guī)格 0.1ml
TNF- Beta(Tumor Necrosis Factor- Beta) 壞死因子-β抗原 0.5mg
IL-18 英文名稱: 白細(xì)胞介素-18/干擾素γ誘導(dǎo)因子抗體 0.1ml
Rhesus antibody Rh TLR2/CD282 Toll樣受體2抗體 規(guī)格 0.1ml
Anti-DcR3/FITC 熒光素標(biāo)記抗誘捕受體3抗體IgGMulti-class antibodies規(guī)格: 0.2ml
solute carrier family 1 溶質(zhì)攜帶物家族-1(抗原)Multi-class antibodies規(guī)格: 0.5mg
Anti-CD73 胞漿-5′-核苷酸酶-Ⅱ抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh OXCT1 含氧酸輔酶A轉(zhuǎn)移酶1抗體 規(guī)格 0.2ml
ADAM15 Kit Human 人 ADAM15 ELISA配對(duì)抗體 ELISA
TMEFF2 英文名稱: 增生肉蛋白1抗體 0.1ml
CCDC87 英文名稱: 卷曲螺旋結(jié)構(gòu)域蛋白87抗體 0.2ml
Anti-CD73 胞漿-5′-核苷酸酶-Ⅱ抗體Multi-class antibodies規(guī)格: 0.1ml
BMP-2 ELISA Kit 大鼠骨成型蛋白2Multi-class antibodies規(guī)格: 48T
Anti-Bcl-2 protein/FITC 熒光素標(biāo)記 Bcl-2 蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Escherichka coli K88-K99/ETECK88 豬源產(chǎn)腸毒素性大腸桿菌K88-K99抗體 規(guī)格 0.2ml
PLAUR/uPAR (Rabbit Urokinase-type Plasminogen Activator Receptor) ELISA Kit 兔尿激酶型纖溶酶原激活物受體 96T
Myosin VIIa 英文名稱: 肌球蛋白7a/常染色體隱性蛋白2抗體 0.2ml
APG4B 英文名稱: 自噬相關(guān)蛋白4B抗體 0.2ml
Anti-Bcl-2 protein/FITC 熒光素標(biāo)記 Bcl-2 蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
TNFSF11 Protein Human 重組人 RANKL / OPGL / TNFSF11 / CD254 蛋白
Dami 人成巨核細(xì)胞細(xì)胞
CD84 Others Mouse 小鼠 CD84 人細(xì)胞裂解液 (陽性對(duì)照)
MHCC-97L人細(xì)胞(低轉(zhuǎn)移) MHCC-97L human hepatoma cells (low metastasis) DMEM+10%FBS
人導(dǎo)管瘤細(xì)胞;BT-474
人結(jié)膜纖維原細(xì)胞(HConF)(5×105 ) HAVSMC, 人主動(dòng)脈平滑肌細(xì)胞 Human
CL-0438SF767(人細(xì)胞)5×106cells/瓶×2
NRG1 Others Canine 狗 NRG1-alpha Protein (ECD) 人細(xì)胞裂解液 (陽性對(duì)照)
人肺動(dòng)脈成纖維細(xì)胞RNAHPAF miRNA5 μg
兔晶體上皮細(xì)胞永生系;N/N1003A(RLE) 細(xì)胞,HCT 116細(xì)胞 M-1細(xì)胞,小鼠腎集合管細(xì)胞(SV40轉(zhuǎn)化)
人胚肺細(xì)胞系;KuMA
HA Others H5N1 甲型 H5N1 (A/Cambodia/R0405050/2007) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽性對(duì)照)
起始識(shí)別復(fù)合蛋白亞基1抗體規(guī)格 TNFSF11 Protein Human 重組人 RANKL / OPGL / TNFSF11 / CD254 蛋白
Dami 人成巨核細(xì)胞細(xì)胞
CD84 Others Mouse 小鼠 CD84 人細(xì)胞裂解液 (陽性對(duì)照)
MHCC-97L人細(xì)胞(低轉(zhuǎn)移) MHCC-97L human hepatoma cells (low metastasis) DMEM+10%FBS
人導(dǎo)管瘤細(xì)胞;BT-474
人結(jié)膜纖維原細(xì)胞(HConF)(5×105 ) HAVSMC, 人主動(dòng)脈平滑肌細(xì)胞 Human
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 起始識(shí)別復(fù)合蛋白亞基1抗體規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)起始識(shí)別復(fù)合蛋白亞基1抗體規(guī)格 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力??贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。